BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Integrated DNA Technologies Release: Enhancing Target Enrichment With Novel Oligonucleotide Technologies


10/31/2013 9:59:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CORALVILLE, IA – 31st October 2013 – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis will be attending NGS 2013 Manchester: Applications & Bottlenecks, on November 5-6. Scientific Application Specialist at IDT, Dr Nick Downey, will present a workshop on November 5, providing delegates with an opportunity to discover how oligonucleotide probes and novel blocking oligonucleotide approaches are improving solution-based target enrichment strategies for next generation sequencing (NGS). As a chance to share expertise and form effective strategies, the workshop run by IDT is ideal for researchers wishing to improve the performance of their targeted enrichment protocols.

As an alternative to whole genome sequencing, target enrichment approaches vastly increase the efficiency of NGS, focusing in on chosen target areas of the genome linked to a specific pathway or disease state. Attendees of the workshop will discover how solution hybridization probe-based enrichment presents significant advantages over PCR-based methods, and how performance is further enhanced by oligonucleotide probes. Furthermore, a new generation of modified blocking oligonucleotides have been shown to increase on-target capture by 10-25 % and their universal barcoded domains alleviate the need for individual barcode specific blockers.

Delegates of NGS can visit the IDT booth to discover how IDT can enhance their research.

For more information please visit www.idtdna.com. Follow us on twitter @idtdna for real-time updates and insights.

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the world, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; Leuven, Belgium; and Singapore. For more information visit www.idtdna.com.

Integrated DNA Technologies

800-328-2661 (US & Canada)

+1 319-626-8400 (outside US)

productinfo@idtdna.com

www.idtdna.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES